FDA approves Abbott’s spinal cord stimulation system for chronic pain — 4 insights

Abbott received FDA approval for Proclaim XR, a neurostimulation device for people suffering from chronic pain.

Advertisement

Four insights:

1. Proclaim XR is a recharge-free platform that provides a low dose of Abbott’s BurstDR stimulation waveform, which copies natural patterns found in the brain.

2. The low dose electric pulses transform pain signals as they travel from the spinal cord to the brain.

3. Proclaim XR has a battery life of up to 10 years.

4. The device also uses Apple mobile software and Bluetooth technology to help manage pain.

More articles on devices:
Dr. Isaac Karikari: Changing attitudes toward opioids and how physicians can drive change
Dr. Timothy Kremchek to operate on Reds rookie Nick Senzel — 4 insights
Icotec to introduce new pedicle screw system — 4 insights 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.